UBS analyst Andrew Mok raised the firm’s price target on HCA Healthcare to $296 from $237 and keeps a Buy rating on the shares, citing his Q4 admissions estimates with UBS census tracker.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HCA: